Viking Global Investors’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,558,563
| Closed | -$35.6M | – | 92 |
|
|
2024
Q3 | $35.6M | Hold |
2,558,563
| – | – | 0.13% | 77 |
|
|
2024
Q2 | $35.3M | Hold |
2,558,563
| – | – | 0.14% | 74 |
|
|
2024
Q1 | $42.3M | Hold |
2,558,563
| – | – | 0.16% | 73 |
|
|
2023
Q4 | $37.4M | Hold |
2,558,563
| – | – | 0.14% | 70 |
|
|
2023
Q3 | $31.4M | Hold |
2,558,563
| – | – | 0.13% | 72 |
|
|
2023
Q2 | $30.5M | Buy |
2,558,563
+1,000,000
| +64% | +$11.9M | 0.13% | 77 |
|
|
2023
Q1 | $20.8M | Hold |
1,558,563
| – | – | 0.1% | 74 |
|
|
2022
Q4 | $33.5M | Hold |
1,558,563
| – | – | 0.17% | 68 |
|
|
2022
Q3 | $31.2M | Sell |
1,558,563
-298,861
| -16% | -$5.99M | 0.14% | 75 |
|
|
2022
Q2 | $33.2M | Buy |
1,857,424
+700,000
| +60% | +$12.5M | 0.15% | 72 |
|
|
2022
Q1 | $11.5M | Hold |
1,157,424
| – | – | 0.05% | 88 |
|
|
2021
Q4 | $19.5M | Sell |
1,157,424
-53,972
| -4% | -$909K | 0.06% | 101 |
|
|
2021
Q3 | $28.7M | Sell |
1,211,396
-130,000
| -10% | -$3.08M | 0.08% | 91 |
|
|
2021
Q2 | $30.5M | Buy |
+1,341,396
| New | +$30.5M | 0.09% | 83 |
|